HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus.

Abstract
Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED50) and 95% effective dose (ED95) of epidural sufentanil as an adjuvant combination with local anesthetics for relief visceral pain in parturients with scarred uterus undergoing elective cesarean section.One hundred parturients with scarred uterus undergoing elective cesarean section under epidural anesthesia were enrolled in this randomized, double-blinded, dose-ranging study. Parturients received 5, 10, 15, 20, and 25 μg epidural sufentanil as an adjuvant with 10 mL of 0.65% ropivacaine. Successful epidural anesthesia was defined as a sixth thoracic vertebra (T6) sensory level achieved within 20 minutes after epidural drugs administration and/or no visceral pain by traction on the abdominal viscera during the cesarean section. The ED50 and ED95 were calculated with a logistic regression model.ED50 and ED95 of epidural sufentanil for successful of the pain-free from visceral pain were 10.7 μg [95% confidence interval (CI): 2.4-14.4 μg) and 28.1 μg (95% CI: 19.4-44.0 μg), respectively. The onset time to sensory block, maximum Bromage scale and duration of motor block were significant different with dose of sufentanil >20 μg (P < .05, compared with the other dose groups). With the dose of epidural sufentanil >20 μg could result in an increase of incidence of maternals' adverse effects. Compared with a different dose of sufentanil, epidural administed sufentanil between 15 μg and 20 μg can maximize parturients' satisfaction.Our study showed that sufentanil could be used in combination with ropivacaine for relief from somato-visceral pain in patients with scarred uterus during elective cesarean section during epidural anesthesia, and that maximized parturients' satisfaction could be achieved when the use of sufentanil with the dose between 15 μg and 20 μg for epidural anesthesia.
AuthorsQiang Lu, Chun-Shan Dong, Jun-Ma Yu, Hao Sun, Peng Sun, Xiang Ma, Chun Luo
JournalMedicine (Medicine (Baltimore)) Vol. 97 Issue 38 Pg. e12404 (Sep 2018) ISSN: 1536-5964 [Electronic] United States
PMID30235712 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Adjuvants, Anesthesia
  • Amides
  • Anesthetics, Local
  • Ropivacaine
  • Sufentanil
Topics
  • Adjuvants, Anesthesia (administration & dosage)
  • Adult
  • Amides (administration & dosage)
  • Anesthesia, Epidural (methods)
  • Anesthesia, Obstetrical (methods)
  • Anesthetics, Local (administration & dosage)
  • Cesarean Section (methods)
  • Cicatrix (complications)
  • Double-Blind Method
  • Female
  • Humans
  • Pregnancy
  • Prospective Studies
  • Ropivacaine
  • Sufentanil (administration & dosage)
  • Treatment Outcome
  • Uterus (pathology)
  • Visceral Pain (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: